14-day Premium Trial Subscription Try For FreeTry Free
$1.75
-0.0600 (-3.31%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.60 $5.47 Friday, 3rd May 2024 LGVN stock ended at $1.75. This is 3.31% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.67% from a day low at $1.73 to a day high of $1.88.
90 days $0.331 $5.47
52 weeks $0.331 $5.47

Historical Longeveron Inc. prices

Date Open High Low Close Volume
Mar 28, 2024 $3.64 $3.64 $3.20 $3.25 147 435
Mar 27, 2024 $2.92 $3.57 $2.92 $3.11 97 926
Mar 26, 2024 $0.395 $0.418 $0.331 $0.344 605 830
Mar 25, 2024 $0.400 $0.430 $0.380 $0.403 302 528
Mar 22, 2024 $0.404 $0.405 $0.370 $0.382 118 142
Mar 21, 2024 $0.368 $0.407 $0.360 $0.390 185 000
Mar 20, 2024 $0.424 $0.440 $0.350 $0.361 423 677
Mar 19, 2024 $0.444 $0.458 $0.440 $0.452 86 218
Mar 18, 2024 $0.474 $0.486 $0.440 $0.441 96 784
Mar 15, 2024 $0.466 $0.476 $0.450 $0.450 58 917
Mar 14, 2024 $0.478 $0.478 $0.460 $0.460 68 692
Mar 13, 2024 $0.465 $0.502 $0.465 $0.471 87 039
Mar 12, 2024 $0.527 $0.529 $0.457 $0.480 229 600
Mar 11, 2024 $0.520 $0.535 $0.511 $0.513 81 725
Mar 08, 2024 $0.520 $0.530 $0.515 $0.520 65 129
Mar 07, 2024 $0.530 $0.538 $0.511 $0.515 75 558
Mar 06, 2024 $0.509 $0.550 $0.508 $0.530 190 755
Mar 05, 2024 $0.530 $0.530 $0.512 $0.527 44 744
Mar 04, 2024 $0.540 $0.550 $0.510 $0.511 74 513
Mar 01, 2024 $0.552 $0.552 $0.525 $0.540 123 314
Feb 29, 2024 $0.530 $0.560 $0.524 $0.534 115 640
Feb 28, 2024 $0.579 $0.579 $0.532 $0.544 264 500
Feb 27, 2024 $0.540 $0.586 $0.535 $0.579 355 251
Feb 26, 2024 $0.520 $0.540 $0.518 $0.540 136 849
Feb 23, 2024 $0.533 $0.533 $0.510 $0.518 101 215
Click to get the best stock tips daily for free!

About Longeveron Inc.

Longeveron. Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a... LGVN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT